Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Osteosarcoma × Ifosfamide × Clear all

Phase

Status

Completed 15 Terminated 5 Unknown 2 Recruiting 2 Not yet recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Sarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Germ Cell and Embryonal 2 Teratoma 1 Seminoma 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Perivascular Epithelioid Cell Neoplasms 1 Osteosarcoma 1 Nonseminomatous germ cell tumor 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nerve Sheath Neoplasms 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Liposarcoma 1 Leukemia, Biphenotypic, Acute 1 Leiomyosarcoma 1 Ichthyosis, X-Linked 1 Hodgkin Disease 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Granuloma, Plasma Cell 1 Germinoma 1 Fibrosarcoma 1

Interventions

X-Rays 4 Phantoms, Imaging 4 Nuclear Medicine Department, Hospital 4 Magnetic Resonance Spectroscopy 4 pembrolizumab 3 Specimen Handling 3 Nivolumab 3 Cyclophosphamide 3 Biopsy 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 regorafenib 2 olaparib 2 larotrectinib 2 ivosidenib 2 ensartinib 2 Etoposide 2 tocilizumab 1 tazemetostat 1 poly ICLC 1 palbociclib 1 naxitamab 1 mifamurtide 1 humanized 3F8 anti-GD2 monoclonal antibody 1 fludarabine phosphate 1 fludarabine 1 flt3 ligand protein 1 etoposide phosphate 1 erdafitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡